Huaren Pharmaceutical Co (SZSE:300110) Total Equity : ¥1,390 Mil (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Huaren Pharmaceutical Co Total Equity?

Huaren Pharmaceutical Co's total equity for the quarter that ended in Mar. 2025 was ¥1,390 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Huaren Pharmaceutical Co Total Equity Historical Data

The historical data trend for Huaren Pharmaceutical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huaren Pharmaceutical Co Total Equity Chart

Huaren Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Equity

Get a 7-Day Free Trial

2,329.52

2,443.43

2,599.73

2,765.96

1,373.93

Huaren Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Equity	Get a 7-Day Free Trial															2,818.33	2,813.48	2,837.23	1,373.93	1,390.48

Huaren Pharmaceutical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Huaren Pharmaceutical Co's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	3428.12	-	2054.192
	=	1,374

Huaren Pharmaceutical Co's Total Equity for the quarter that ended in Mar. 2025 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2025 )	-	Total Liabilities(Q: Mar. 2025 )
	=	3450.164	-	2059.689
	=	1,390

Huaren Pharmaceutical Co Total Equity Related Terms

Thank you for viewing the detailed overview of Huaren Pharmaceutical Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Huaren Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huaren Pharmaceutical Co Ltd (SZSE:300110) » Definitions » Total Equity

Traded in Other Exchanges

N/A

Address

No. 187 Zhuzhou Road, Qingdao, Shandong, CHN, 266100

Website

http://www.qdhuaren.com

Huaren Pharmaceutical Co Ltd is a China-based company engaged in the manufacture, and sale of non-polyvinyl chloride and Non-PVC large capacity preparations. Its categories of products include conventional infusion, therapy infusion, and nutrition infusion. The company distributes its products in domestic market, with Northeast China as its main market.

Executives

Yang Xiao Dong	Director
Bo Guo Xiu	Executives
Zhou Xi Jian	Director
Mao Yu Wei	Supervisors
Chu Xiao Jun	Executives
Zhou Qiang	Directors, executives
Ji Sheng Bin	Executives
Xiao Wei Wen	Executives
Shen Hong Ce	Executives
Li Xiao Li	Executives
Liu Qian	Executives
Wang Wen Ping	Executives
Liang Fu You	Director
Liang Fu Dong	Director
Gong Ling	Secretary Dong

Huaren Pharmaceutical Co Headlines

No Headlines